NO2987793T3 - - Google Patents

Info

Publication number
NO2987793T3
NO2987793T3 NO14786115A NO14786115A NO2987793T3 NO 2987793 T3 NO2987793 T3 NO 2987793T3 NO 14786115 A NO14786115 A NO 14786115A NO 14786115 A NO14786115 A NO 14786115A NO 2987793 T3 NO2987793 T3 NO 2987793T3
Authority
NO
Norway
Application number
NO14786115A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2987793T3 publication Critical patent/NO2987793T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
NO14786115A 2013-04-18 2014-04-18 NO2987793T3 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013087151 2013-04-18
PCT/JP2014/061007 WO2014171528A1 (ja) 2013-04-18 2014-04-18 ヘテロ環酢酸アミド化合物

Publications (1)

Publication Number Publication Date
NO2987793T3 true NO2987793T3 (zh) 2018-03-24

Family

ID=51729480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14786115A NO2987793T3 (zh) 2013-04-18 2014-04-18

Country Status (33)

Country Link
US (2) US8937087B2 (zh)
EP (1) EP2987793B1 (zh)
JP (1) JP6252582B2 (zh)
KR (1) KR102193247B1 (zh)
CN (1) CN105121435B (zh)
AR (1) AR095883A1 (zh)
AU (1) AU2014254768B2 (zh)
BR (1) BR112015026512B1 (zh)
CA (1) CA2909783C (zh)
CY (1) CY1119754T1 (zh)
DK (1) DK2987793T3 (zh)
EA (1) EA028968B1 (zh)
ES (1) ES2651866T3 (zh)
HK (1) HK1214248A1 (zh)
HR (1) HRP20171786T1 (zh)
HU (1) HUE036054T2 (zh)
IL (1) IL241962B (zh)
LT (1) LT2987793T (zh)
ME (1) ME02891B (zh)
MX (1) MX2015014646A (zh)
MY (1) MY175971A (zh)
NO (1) NO2987793T3 (zh)
NZ (1) NZ713118A (zh)
PH (1) PH12015502341B1 (zh)
PL (1) PL2987793T3 (zh)
PT (1) PT2987793T (zh)
RS (1) RS56865B1 (zh)
SA (1) SA515370015B1 (zh)
SG (1) SG11201508448RA (zh)
SI (1) SI2987793T1 (zh)
TW (1) TWI625329B (zh)
UA (1) UA116243C2 (zh)
WO (1) WO2014171528A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR105025A1 (es) * 2015-06-19 2017-08-30 Astellas Pharma Inc Compuesto de imidazodiazepina
TWI725408B (zh) 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
AU2019339186A1 (en) 2018-09-13 2021-03-25 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
CN110590576A (zh) * 2019-08-15 2019-12-20 安徽金禾实业股份有限公司 一种4-多氟代甲氧基邻苯二胺的制备方法
CN114380709B (zh) * 2021-12-31 2023-07-21 西北农林科技大学 4-氯-2-酰氨基酚的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE277927T1 (de) * 1999-04-02 2004-10-15 Neurogen Corp Aryl- und heteroaryl-kondensierte aminoalkyl- imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
US6627624B1 (en) 1999-04-02 2003-09-30 Neurogen Corporation Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
AUPQ309399A0 (en) 1999-09-28 1999-10-21 Fujisawa Pharmaceutical Co., Ltd. Benzothiazoline derivatives
JP2005508907A (ja) 2001-09-14 2005-04-07 ノボ　ノルディスク　アクティーゼルスカブ ヒスタミンｈ３受容体に選択的に結合する置換されたピペリジン
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
NZ534757A (en) 2002-03-12 2006-07-28 Merck & Co Inc Substituted amides
CA2519475A1 (en) 2003-03-14 2004-09-30 Merck & Co., Inc. Bicyclic anilide spirohydantoin cgrp receptor antagonists
CN1922141A (zh) * 2004-02-23 2007-02-28 大日本住友制药株式会社 新的杂环化合物
ATE440826T1 (de) * 2004-05-27 2009-09-15 Ucb Pharma Sa Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen
US7790726B2 (en) 2005-08-16 2010-09-07 Chemocentryx, Inc. Monocyclic and bicyclic compounds and methods of use
WO2007044885A2 (en) 2005-10-11 2007-04-19 Chemocentryx, Inc. Piperidine derivatives and methods of use
CL2007002097A1 (es) 2006-07-20 2008-01-18 Smithkline Beecham Corp Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
US7786157B2 (en) 2007-03-16 2010-08-31 Chemocentryx, Inc. OXO-imidazolidines as modulators of chemokine receptors
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
GB0713686D0 (en) * 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2

Also Published As

Publication number Publication date
HUE036054T2 (hu) 2018-06-28
DK2987793T3 (en) 2017-12-18
RS56865B1 (sr) 2018-04-30
TW201518298A (zh) 2015-05-16
SG11201508448RA (en) 2015-11-27
EP2987793B1 (en) 2017-10-25
EA201591988A1 (ru) 2016-02-29
AU2014254768A1 (en) 2015-11-05
MY175971A (en) 2020-07-19
PH12015502341A1 (en) 2016-02-22
PT2987793T (pt) 2017-12-19
SI2987793T1 (en) 2018-02-28
US8937087B2 (en) 2015-01-20
BR112015026512B1 (pt) 2023-03-14
HK1214248A1 (zh) 2016-07-22
EP2987793A4 (en) 2016-09-07
US20150045402A1 (en) 2015-02-12
EP2987793A1 (en) 2016-02-24
UA116243C2 (uk) 2018-02-26
US20140315963A1 (en) 2014-10-23
ES2651866T3 (es) 2018-01-30
EA028968B1 (ru) 2018-01-31
WO2014171528A1 (ja) 2014-10-23
NZ713118A (en) 2019-03-29
IL241962B (en) 2019-03-31
AR095883A1 (es) 2015-11-18
PL2987793T3 (pl) 2018-05-30
AU2014254768B2 (en) 2017-10-05
LT2987793T (lt) 2018-01-10
KR102193247B1 (ko) 2020-12-22
CY1119754T1 (el) 2018-06-27
PH12015502341B1 (en) 2016-02-22
BR112015026512A2 (pt) 2017-07-25
CN105121435B (zh) 2017-09-29
HRP20171786T1 (hr) 2018-02-23
MX2015014646A (es) 2016-03-01
CA2909783C (en) 2021-02-02
TWI625329B (zh) 2018-06-01
CA2909783A1 (en) 2014-10-23
JPWO2014171528A1 (ja) 2017-02-23
SA515370015B1 (ar) 2017-11-27
JP6252582B2 (ja) 2017-12-27
US9708307B2 (en) 2017-07-18
KR20150143468A (ko) 2015-12-23
CN105121435A (zh) 2015-12-02
ME02891B (me) 2018-04-20

Similar Documents

Publication Publication Date Title
AP2016009275A0 (zh)
BR112015007533A2 (zh)
BR102016010778A2 (zh)
BR112014017733A2 (zh)
BR112014017739A2 (zh)
BR112014018502A2 (zh)
BR112014019326A2 (zh)
BR112014018516A2 (zh)
BR112014018480A2 (zh)
BR112014017765A2 (zh)
BR112014017855A2 (zh)
BR112014017669A2 (zh)
BR112014021878A2 (zh)
BR112014018468A2 (zh)
BR112014018207A2 (zh)
BR112014017901A2 (zh)
BR112014019204A2 (zh)
BR112015015948A2 (zh)
BR112014017722A2 (zh)
BR112015016283A2 (zh)
BR112014018578A2 (zh)
BR112014018483A2 (zh)
BR112014017794A2 (zh)
BR112014017653A2 (zh)
BR112014017601A2 (zh)